Methodology

All entries for: ChainGen Biopharma Ltd.

October 17, 2025

ChainGen Biopharma Ltd.

Orphan Drug Designation

FDA orphan drug designation: treatment of myotonic dystrophy type 1 (DM1)

Disease Area: Rare Diseases
Source
Facebook Linkedin
Main Menu
Scroll to Top